Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy

被引:10
作者
Bandyopadhyay, A. [1 ]
Bhattacharyya, S. [1 ]
机构
[1] Calcutta Med Coll, Dept Pediat, Kolkata, India
来源
ANNALS OF TROPICAL PAEDIATRICS | 2008年 / 28卷 / 04期
关键词
D O I
10.1179/146532808X375440
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Growth in HIV-infected children generally improves with antiretroviral therapy (ART). Little is known about the effect of pre-existing malnutrition on response to treatment. Aim: To evaluate prospectively the effect of pre-existing malnutrition on growth of HIV-infected children commenced on ART compared with those without pre-existing malnutrition. Methods: Inclusion criteria were children (2 months to 8.5 years) who were commenced on ART. Exclusion criteria were pre-treatment with ART, virological non-responders and co-existing tuberculous infection. Weight-for-age (WAZ) and height-for-age Z scores (HAZ) <= -2 at the initiation of treatment were the criteria for malnutrition. Monthly height and weight measurements were made for 18 months (2007-2008) after initiation of ART. Z scores were used to express changes in standard deviation (SD) units for each of the children at 0 and 18 months of the study using WHO height and weight reference curves for age and gender. The changes in Z score were compared within the groups by paired t-test and in both groups by the Mann-Whitney U test. Results: The subjects were grouped as malnourished (G1) and not malnourished (G2) before initiation of treatment. There was a significant increase in HAZ score (mean - 0.15, p = 0.006) and WAZ score (mean - 0.09, p = 0.034) in G1 and also HAZ score (mean - 0.29, p < 0.001) and WAZ score (mean - 0.30, p = 0.001) in G2. There was a trend toward a significantly greater Z-score change in G2 than in G1 for height (p = 0.027) and weight (p = 0.046). Conclusion: In HIV-infected children, pre-existing malnutrition may impair nutritional response to ART.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 24 条
[1]  
[Anonymous], 2006, WHO CAS DEF HIV SURV
[2]   Growth failure as a prognostic indicator of mortality in pediatric HIV infection [J].
Berhane, R ;
Bagenda, D ;
Marum, L ;
Aceng, E ;
Ndugwa, C ;
Bosch, RJ ;
Olness, K .
PEDIATRICS, 1997, 100 (01) :art. no.-e7
[3]   Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa [J].
Bobat, R ;
Coovadia, H ;
Moodley, D ;
Coutsoudis, A ;
Gouws, E .
ANNALS OF TROPICAL PAEDIATRICS, 2001, 21 (03) :203-210
[4]   Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children [J].
Dreimane, D ;
Nielsen, K ;
Deveikis, A ;
Bryson, YJ ;
Geffner, ME .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (03) :315-316
[5]   Experience of anti-retroviral treatment for HIV-infected children in Malawi: the 1st 12 months [J].
Ellis, Jane ;
Molyneux, Elizabeth M. .
ANNALS OF TROPICAL PAEDIATRICS, 2007, 27 (04) :261-267
[6]  
Gilden D, 1997, GMHC Treat Issues, V11, P12
[7]  
Gilden D, 1997, GMHC Treat Issues, V11, P12
[8]   Management of gastrointestinal disorders in children with HIV infection [J].
Guarino A. ;
Bruzzese E. ;
De Marco G. ;
Buccigrossi V. .
Pediatric Drugs, 2004, 6 (6) :347-362
[9]   Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania [J].
Johannessen, Asgeir ;
Naman, Ezra ;
Ngowi, Bernard J. ;
Sandvik, Leiv ;
Matee, Mecky I. ;
Aglen, Henry E. ;
Gundersen, Svein G. ;
Bruun, Johan N. .
BMC INFECTIOUS DISEASES, 2008, 8 (1)
[10]  
Jones Brian M, 2005, MedGenMed, V7, P71, DOI 10.1186/1758-2652-7-2-71